C
Amphastar Pharmaceuticals, Inc. AMPH
$29.79 -$0.715-2.34% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 22.72% -33.40% -6.10% 6.54% -12.11%
Total Depreciation and Amortization 6.79% 3.70% 1.60% 2.04% 1.30%
Total Amortization of Deferred Charges 10.50% 5.25% -2.69% -69.46% 14.47%
Total Other Non-Cash Items -43.00% 166.95% -234.71% 96.55% 80.78%
Change in Net Operating Assets -10.84% -94.58% -17.24% -184.85% 218.86%
Cash from Operations 1.47% 20.86% -51.60% -13.24% 24.99%
Capital Expenditure 1.23% 13.81% 10.02% -128.21% 31.26%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- 100.00% --
Divestitures -- -- -- -- --
Other Investing Activities -53.06% 191.02% -11.90% -131.92% 171.08%
Cash from Investing -105.96% 129.38% -3.16% 50.52% -558.77%
Total Debt Issued 151.46% -66.27% -48.80% 38,132.00% -100.61%
Total Debt Repaid 2.63% 66.96% -180.49% 99.49% -8,072.45%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -120.18% 59.38% -21.84% -1,081.36% 84.50%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 40.05% -2,018.18% 103.75% -58,800.00% 100.40%
Cash from Financing -108.25% 57.14% -48.33% -112.92% 21.08%
Foreign Exchange rate Adjustments 20.34% 1,172.73% 82.54% -231.58% 80.41%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -84.26% 176.96% -1,722.23% 121.66% -120.28%